Grantham, Mayo, Van Otterloo & Co (GMO)
TBI

Grantham, Mayo, Van Otterloo & Co (GMO)’s Trueblue TBI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,115
Closed -$392K – 680
2023
Q2 		$392K Buy
22,115
+6,815
+45% +$116K ﹤0.01% 582
2023
Q1 		$272K Buy
15,300
+1,700
+13% +$31.8K ﹤0.01% 625
2022
Q4 		$266K Buy
+13,600
New +$276K ﹤0.01% 647
2022
Q3 		– Sell
-30,693
Closed -$549K – 786
2022
Q2 		$549K Sell
30,693
-35,000
-53% -$821K ﹤0.01% 600
2022
Q1 		$1.9M Buy
65,693
+3,500
+6% +$96.2K 0.01% 457
2021
Q4 		$1.72M Buy
62,193
+10,000
+19% +$283K 0.01% 484
2021
Q3 		$1.41M Buy
+52,193
New +$1.4M 0.01% 496
2021
Q2 		– Sell
-43,593
Closed -$960K – 839
2021
Q1 		$960K Buy
43,593
+5,893
+16% +$121K 0.01% 601
2020
Q4 		$705K Sell
37,700
-2,400
-6% -$43.2K ﹤0.01% 631
2020
Q3 		$621K Sell
40,100
-14,700
-27% -$227K ﹤0.01% 597
2020
Q2 		$837K Buy
54,800
+36,300
+196% +$539K 0.01% 560
2020
Q1 		$236K Buy
+18,500
New +$331K ﹤0.01% 687
2017
Q3 		– Sell
-8,680
Closed -$230K – 632
2017
Q2 		$230K Sell
8,680
-55,273
-86% -$1.48M ﹤0.01% 530
2017
Q1 		$1.75M Sell
63,953
-18,816
-23% -$480K 0.01% 332
2016
Q4 		$2.04M Sell
82,769
-75,464
-48% -$1.59M 0.01% 315
2016
Q3 		$3.59M Sell
158,233
-182,805
-54% -$3.99M 0.02% 281
2016
Q2 		$6.45M Buy
341,038
+136,238
+67% +$2.84M 0.03% 272
2016
Q1 		$5.36M Buy
204,800
+159,100
+348% +$3.68M 0.02% 290
2015
Q4 		$1.18M Buy
+45,700
New +$1.23M ﹤0.01% 384

Other funds holding TBI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s TBI Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Trueblue (TBI) in Q3 2023, closing a stake of 22,115 shares — an estimated $392K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in TBI in Q4 2015 and held it in 19 quarters. The position peaked at $6.45M in Q2 2016. 144 funds tracked by Wall St. Rank hold TBI as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Trueblue position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 22,115 Trueblue shares in Q3 2023, an estimated $392K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Trueblue in Q4 2015 and held it in 19 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Trueblue position peaked at $6.45M in Q2 2016.
  • 144 funds tracked by Wall St. Rank held Trueblue as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.